QUARTERLY RESULTS
Emcure Pharmaceuticals Ltd.
BSE
Jun 16, 09:54
1335.20
-27.50 ( -2.02%)
Volume
1311
Prev. Close
1362.70
Open Price
1320.05
Bid Price(Qty.)
1333.85 (17)
Offer Pr.(Qty.)
1337.00 (16)
NSE
Jun 16, 09:44
1350.50
-10.90 ( -0.80%)
Volume
10098
Prev. Close
1361.40
Open Price
1362.20
Bid Price(Qty.)
1349.60 (11)
Offer Pr.(Qty.)
1351.20 (11)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE168P01015
|
Market Cap. ( ₹ in Cr. )
|
25593.10
|
P/BV
|
6.21
|
Book Value ( ₹ )
|
217.34
|
|
BSE Code
|
544210
|
52 Week High/Low ( ₹ )
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.56
|
|
NSE Code
|
EMCUREEQ
|
Book Closure
|
|
EPS ( ₹ )
|
35.95
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Net Sales/Income from operations | 1278.19 | 1028.81 | 1104.63 | 970.29 | 902.55 |
| Total Income From Operations | 1278.19 | 1028.81 | 1104.63 | 970.29 | 902.55 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 365.01 | 350.91 | 325.99 | 266.07 | 298.90 |
| Purchase of Traded Goods | 259.83 | 175.31 | 232.11 | 158.46 | 140.34 |
| Increase/Decrease in Stocks | -16.86 | -47.69 | -53.30 | -8.42 | -81.41 |
| Employees Cost | 198.16 | 196.01 | 191.12 | 195.09 | 174.35 |
| Depreciation | 56.91 | 56.65 | 56.34 | 55.08 | 39.46 |
| Other Expenses | 227.41 | 229.86 | 256.56 | 243.91 | 264.05 |
| Total Expenses | 1090.46 | 961.04 | 1008.81 | 910.18 | 835.70 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 187.73 | 67.77 | 95.82 | 60.11 | 66.85 |
| Other Income | 22.40 | 19.41 | 54.93 | 32.51 | 34.16 |
| P/L Before Interest, Excpt. Items & Tax | 210.12 | 87.18 | 150.76 | 92.62 | 101.01 |
| Interest | 24.07 | 19.93 | 31.40 | 37.57 | 56.22 |
| P/L Before Exceptional Items & Tax | 186.05 | 67.25 | 119.36 | 55.05 | 44.79 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -9.32 |
| P/L Before Tax | 186.05 | 67.25 | 119.36 | 55.05 | 35.47 |
| Tax | 46.50 | 17.05 | 32.44 | 14.60 | 6.50 |
| P/L After Tax from Ordinary Activities | 139.56 | 50.20 | 86.92 | 40.45 | 28.98 |
| Net Profit/Loss For the Period | 139.56 | 50.20 | 86.92 | 40.45 | 28.98 |
| | | | | | |
| Equity Share Capital | 189.48 | 189.43 | 189.10 | 181.15 | 181.15 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 7.37 | 2.65 | 4.62 | 2.23 | 1.60 |
| Diluted EPS (Rs.) | 7.37 | 2.65 | 4.62 | 2.23 | 1.60 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 7.37 | 2.65 | 4.62 | 2.23 | 1.60 |
| Diluted EPS (Rs.) | 7.37 | 2.65 | 4.62 | 2.23 | 1.60 |
| | | | | | |
| PBITOE Margin (%) | 14.68 | 6.58 | 8.67 | 6.19 | 7.40 |
| PBTE Margin (%) | 14.55 | 6.53 | 10.80 | 5.67 | 4.96 |
| PBT Margin (%) | 14.55 | 6.53 | 10.80 | 5.67 | 3.93 |
| PAT Margin (%) | 10.91 | 4.87 | 7.86 | 4.16 | 3.21 |